NCT04892472 · Interventional trial
EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer
Overall registry status Terminated
Phase 2
Conditions Non-small Cell Lung Cancer
Delaware Valley sites
- Lankenau Medical Center · Wynnewood, PA · Montgomery County
First posted
Registry updated
Added to the directory